Q4 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Cellyan Biotechnology(HKPD) the Revenue is 3.148 M (-31.73%);the EBIT is -608.18 K (-45.67%);the EPS is -0.0274 (+29.55%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B31.73%
----
----
EBIT
-0.00B45.67%
----
----
EPS
-0.027429.55%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf